ADAGE CAPITAL PARTNERS GP, L.L.C.
Q2 2022 13F-HR Holdings
Net value change ($000)
-9,033,433
(-17.2%)
New positions
107
Sold out positions
109
Turnover %
8.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Biohaven Pharmaceutical Holding Co Ltd. | 420,298 | 1865.7% |
| SVB FINANCIAL GROUP | 101,649 | 104.9% |
| SNY | 90,745 | 1497.9% |
| TWTR | 88,145 | 272.8% |
| LLY | 80,625 | 28.6% |
| BAH | 75,637 | NEW |
| HR | 71,823 | 411.5% |
| KEY | 62,489 | 429.5% |
| EL | 61,473 | NEW |
| DG | 58,488 | NEW |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|